These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5529405)

  • 1. Development of a non-infective protective antigen against louping-ill (arbovirus group B). Laboratory experiments.
    Brotherston JG; Boyce JB
    J Comp Pathol; 1970 Jul; 80(3):377-88. PubMed ID: 5529405
    [No Abstract]   [Full Text] [Related]  

  • 2. Field trials of an inactivated oil-adjuvant vaccine against louping-ill (Arbovirus group B).
    Brotherston JG; Bannatyne CC; Mathieson AO; Nicolson TB
    J Hyg (Lond); 1971 Sep; 69(3):479-89. PubMed ID: 5285947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response of sheep following administration of louping-ill virus vaccine.
    Reid HW; Pow I
    Vet Rec; 1995 Jun; 136(25):638-9. PubMed ID: 7571273
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunogenic fragment antigens from tissue cultures infected with the virus of louping-ill (arbovirus group B).
    Brotherston JG; Boyce JB
    J Gen Microbiol; 1969 Dec; 59(3):i. PubMed ID: 5374022
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody responses to vaccination against louping-ill virus in newborn lambs.
    Wells PW; Reid HW
    J Comp Pathol; 1978 Jul; 88(3):425-31. PubMed ID: 209066
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune responses of sheep to louping-ill virus vaccine.
    Shaw B; Reid HW
    Vet Rec; 1981 Dec; 109(24):529-31. PubMed ID: 6280367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Louping-ill encephalomyelitis in the sheep. VI. Infection of the 120-day foetus.
    Doherty PC; Vantsis JT; Hart R
    J Comp Pathol; 1972 Oct; 82(4):385-92. PubMed ID: 4567459
    [No Abstract]   [Full Text] [Related]  

  • 8. THE EPIDEMIOLOGY OF LOUPING ILL IN AYRSHIRE: THE FIRST YEAR OF STUDIES IN SHEEP.
    SMITH CE; MCMAHON DA; O'REILLY KJ; WILSON AL; ROBERTSON JM
    J Hyg (Lond); 1964 Mar; 62(1):53-68. PubMed ID: 14128320
    [No Abstract]   [Full Text] [Related]  

  • 9. Variations in the haemagglutinin content of crude mouse brain antigens containing louping ill virus.
    Timoney PJ
    Res Vet Sci; 1971 Sep; 12(5):490-1. PubMed ID: 5107106
    [No Abstract]   [Full Text] [Related]  

  • 10. Louping ill virus vaccination of dogs.
    Thomson JR; Reid HW
    Vet Rec; 1987 Jan; 120(4):94. PubMed ID: 3824860
    [No Abstract]   [Full Text] [Related]  

  • 11. Sequencing and antigenic studies of a Norwegian virus isolated from encephalomyelitic sheep confirm the existence of louping ill virus outside Great Britain and Ireland.
    Gao GF; Jiang WR; Hussain MH; Venugopal K; Gritsun TS; Reid HW; Gould EA
    J Gen Virol; 1993 Jan; 74 ( Pt 1)():109-14. PubMed ID: 8380831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and evaluation of a formalin-killed Chikungunya vaccine.
    Harrison VR; Eckels KH; Bartelloni PJ; Hampton C
    J Immunol; 1971 Sep; 107(3):643-7. PubMed ID: 4999088
    [No Abstract]   [Full Text] [Related]  

  • 13. Louping-ill encephalomyelitis in the sheep. I. The relationship of viraemia and the antibody response to susceptibility.
    Reid HW; Doherty PC
    J Comp Pathol; 1971 Oct; 81(4):521-9. PubMed ID: 5135640
    [No Abstract]   [Full Text] [Related]  

  • 14. The serological response and long-lasting resistance against infection with louping-ill virus in sheep immunized with a highly attenuated tick-borne encephalitis virus.
    Mayer V; Blaskovic D; Ernek E; Libíková H
    J Hyg (Lond); 1969 Dec; 67(4):731-8. PubMed ID: 4982559
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of methods of measuring the persistence of neutralizing and haemagglutinin-inhibiting antibodies to louping ill virus in experimentally infected sheep.
    O'Reilly KJ; Smith CE; McMahon DA; Bowen ET; White G
    J Hyg (Lond); 1968 Jun; 66(2):217-27. PubMed ID: 5250130
    [No Abstract]   [Full Text] [Related]  

  • 16. Louping-ill and Semliki forest virus infections in the short-tailed vole Microtus agrestis (L.).
    Seamer J; Zlotnik I
    Br J Exp Pathol; 1970 Aug; 51(4):385-93. PubMed ID: 5530345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative immunogenicities of chikungunya vaccines prepared in avian and mammalian tissues.
    Harrison VR; Binn LN; Randall R
    Am J Trop Med Hyg; 1967 Nov; 16(6):786-91. PubMed ID: 4965219
    [No Abstract]   [Full Text] [Related]  

  • 18. Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine.
    Klockmann U; Krivanec K; Stephenson JR; Hilfenhaus J
    Vaccine; 1991 Mar; 9(3):210-2. PubMed ID: 2042394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppression in toxoplasmosis: further studies on mice infected with louping-ill virus.
    Reid HW; Buxton D; Pow I; Finlayson J
    J Med Microbiol; 1980 May; 13(2):313-8. PubMed ID: 6247491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Louping ill in man: a forgotten disease.
    Davidson MM; Williams H; Macleod JA
    J Infect; 1991 Nov; 23(3):241-9. PubMed ID: 1753132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.